-
3 days ago | 
themarketsdaily.com | Mitch Edgeman
Iams Wealth Management LLC lifted its stake in Eli Lilly and Company ( NYSE:LLY - Free Report) by 13.9% in the first quarter, Holdings Channel.com reports. The firm owned 368 shares of the company's stock after acquiring an additional 45 shares during the quarter. Iams Wealth Management LLC's holdings in Eli Lilly and Company were worth $304,000 as of its most recent SEC filing.
-
3 days ago | 
themarketsdaily.com | Mitch Edgeman
Contravisory Investment Management Inc. purchased a new position in Principal Financial Group, Inc. ( NYSE:PFG - Free Report) during the 1st quarter, HoldingsChannel reports. The firm purchased 6,207 shares of the company's stock, valued at approximately $524,000. Several other hedge funds have also made changes to their positions in the stock. Curio Wealth LLC bought a new stake in Principal Financial Group during the 4th quarter valued at $29,000.
-
3 days ago | 
themarketsdaily.com | Mitch Edgeman
GeneDx Holdings Corp. ( NASDAQ:WGS - Get Free Report) CFO Kevin Feeley sold 370 shares of the company's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $71.26, for a total transaction of $26,366.20. Following the sale, the chief financial officer now directly owns 4,105 shares in the company, valued at approximately $292,522.30. This trade represents a 8.27% decrease in their ownership of the stock.
-
3 days ago | 
themarketsdaily.com | Mitch Edgeman
Ibotta, Inc. ( NYSE:IBTA - Get Free Report) major shareholder Jermoluk Founders Fund I. Clark sold 5,000 shares of the firm's stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $49.06, for a total transaction of $245,300.00. Following the sale, the insider now owns 534,638 shares of the company's stock, valued at approximately $26,229,340.28. The trade was a 0.93% decrease in their ownership of the stock.
-
3 days ago | 
themarketsdaily.com | Mitch Edgeman
Omega Flex, Inc. ( NASDAQ:OFLX - Get Free Report) saw a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 49,900 shares, a growth of 25.1% from the April 30th total of 39,900 shares. Approximately 1.4% of the company's stock are short sold. Based on an average daily volume of 24,900 shares, the days-to-cover ratio is currently 2.0 days. Institutional investors and hedge funds have recently bought and sold shares of the stock.
-
3 days ago | 
themarketsdaily.com | Mitch Edgeman
Tilly's, Inc. ( NYSE:TLYS - Get Free Report) was the target of a large growth in short interest during the month of May. As of May 15th, there was short interest totalling 1,630,000 shares, a growth of 25.4% from the April 30th total of 1,300,000 shares. Approximately 7.3% of the company's stock are short sold. Based on an average daily volume of 217,300 shares, the short-interest ratio is currently 7.5 days. Shares of NYSE TLYS opened at $1.34 on Thursday.
-
3 days ago | 
themarketsdaily.com | Mitch Edgeman
Rand Capital Co. ( NASDAQ:RAND - Get Free Report) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 2,500 shares, an increase of 25.0% from the April 30th total of 2,000 shares. Approximately 0.4% of the company's shares are short sold. Based on an average daily trading volume, of 11,800 shares, the days-to-cover ratio is presently 0.2 days. A hedge fund recently bought a new stake in Rand Capital stock.
-
3 days ago | 
themarketsdaily.com | Mitch Edgeman
E3 Lithium Limited ( CVE:ETL - Free Report) - Investment analysts at Roth Capital reduced their FY2025 earnings estimates for E3 Lithium in a research report issued to clients and investors on Tuesday, June 3rd. Roth Capital analyst J. Reagor now expects that the company will post earnings per share of ($0.13) for the year, down from their prior estimate of ($0.12). The consensus estimate for E3 Lithium's current full-year earnings is ($0.10) per share.
-
3 days ago | 
themarketsdaily.com | Mitch Edgeman
Uranium Energy Corp. ( NYSEAMERICAN:UEC - Free Report) - Equities researchers at Roth Capital decreased their FY2025 earnings estimates for Uranium Energy in a report released on Tuesday, June 3rd. Roth Capital analyst J. Reagor now expects that the basic materials company will earn ($0.17) per share for the year, down from their prior forecast of ($0.13). The consensus estimate for Uranium Energy's current full-year earnings is $0.01 per share.
-
3 days ago | 
themarketsdaily.com | Mitch Edgeman
Nu Skin Enterprises, Inc. ( NYSE:NUS - Get Free Report) Director Edwina D. Woodbury sold 4,532 shares of the stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $8.44, for a total transaction of $38,250.08. Following the completion of the transaction, the director now directly owns 42,947 shares of the company's stock, valued at approximately $362,472.68. The trade was a 9.55% decrease in their position.
